Chronic infusion of norepinephrine into the VMH of normal rats induces the obese glucose-intolerant state

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 278, Issue 2 47-2, 2000, Pages

  Cincotta, Anthony H ^a,b   Luo, Shuqin ^a   Zhang, Ying ^a   Liang, Yin ^a   Bina, Keshavan G ^a   Jetton, Thomas L ^a   Scislowski, Piotr W D ^a  

^a Ergo Science Corporation   (United States)

^b NONE   (United States)

Author keywords

Insulin resistance; Leptin; Neuroendocrine; Obesity; Respiratory quotient; Ventromedial hypothalamus

Indexed keywords

FAT; GLUCAGON; GLUCOSE; INSULIN; LEPTIN; NORADRENALIN; TRIACYLGLYCEROL;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; FEMALE; GLUCOSE INTOLERANCE; HYPOTHALAMUS VENTROMEDIAL NUCLEUS; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; NONHUMAN; OBESITY; PRIORITY JOURNAL; RAT; RESPIRATORY QUOTIENT; ZONA INCERTA;

EID: 0034099771     PISSN: 03636119     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpregu.2000.278.2.r435     Document Type: Article

References (51)

1. Amir, S. Intra-ventromedial hypothalamic injection of glutamate stimulates brown adipose tissue thermogenesis in the rat. Brain Res. 511: 341-344, 1990.
2. Amir, S., A. Schiavetto, and R. Pollock. Insulin co-injection suppresses the thermogenic response to glutamate microinjection into the VMH in rats. Brain Res. 527: 326-329, 1990.
3. Bartness, T. J., and G. N. Wade. Photoperiodic control of seasonal body weight cycles in hamsters. Neurosci. Biobehav. Rev. 9: 599-612, 1995.
4. Belfiore, F., and S. Iannello. Insulin resistance in obesity: metabolic mechanisms and measurement methods. Mol. Genet. Metab. 65: 121-128, 1998.
5. Beverly, J. L., L. Arseneau, and M. Devries. Norepinephrine mediates the increase in GABA activity in VMH after 2-DG in rats (Abstract). Diabetes 47, Suppl. 1: A294, 1998.
6. Boden, G. Role of fatty acids in the pathogenesis of insulin resistance and NIDDM. Diabetes 46: 3-10, 1997.
7. Boundy, V. A., and A. H. Cincotta. Hypothalamic adrenergic receptor changes in the metabolic syndrome of ob/ob mice. Diabetes 48, Suppl. 1: A285, 1999.
8. Cincotta, A. H., T. A, MacEachern, and A. H. Meier. Bromocriptine redirects metabolism and prevents seasonal onset of obese hyperinsulinemic state in Syrian hamsters. Am. J. Physiol. Endocrinol. Metab. 264: E285-E293, 1993.
9. De Jong, A., J. H. Strubbe, and A. B. Steffens. Hypothalamic influence on insulin and glucagon release in the rat. Am. J. Physiol. Endocrinol. Metab. Gastrointest. Physiol. 233: E380-E388, 1977.
10. Dole, V. P. A relation between nonesterified fatty acids plasma and the metabolism of glucose. J. Clin. Invest. 35: 150-154, 1956.
11. Felber, L., E. Ferrannini, A. Golay, H. U. Meyer, D. Theibaud, B. Curchod, E. Maeder, E. Jequier, and R. A. DeFronzo. Role of lipid oxidation in pathogenesis of insulin resistance of obesity and type II diabetes. Diabetes 36: 1341-1350, 1987.
12. Ferrannini, E., and A. Mari. How to measure insulin sensitivity. J. Hypertens. 16: 895-906, 1998.
13. Florant, G. L., and W. A. Bauman. Seasonal variations in carbohydrate metabolism in mammalian hibernators: insulin and body weight changes. In: Recent Advances in Obesity Research, edited by T. B. Van Itallie and J. Hirsch. London: Liberty, 1984, vol. 4, p 57-64.
14. Frohman, L. A. Hypothalamic control of metabolism. In: Handbook of the Hypothalamus. Physiology of the Hypothalamus, edited by P. J. Morgane and J. Panksepp. New York: Dekker, 1980, vol. 2, p. 519-555.
15. Garris, D. R. Developmental and regional changes in brain norepinephrine levels in diabetic C57BL/KsJ mice: effects of estradiol and progesterone. Brain Res. 89: 314-319, 1995.
16. Grundy, S. M. Hypertriglyceridemia, atherogenic dyslipidemia, and the metabolic syndrome. Am. J. Cardiol. 81: 18B-25B, 1998.
17. Hetherington, A. W., and S. W. Ranson. The relation of various hypothalamic lesions to adiposity in the rat. J. Comp. Neurol. 76: 475-499, 1942.
18. Jacob, R., J. Dziura, M. B. Medwick, P. Leone, S. Caprio, M. During, G. I. Shulman, and R. S. Sherwin. The effect of leptin is enhanced by microinjection into the ventromedial hypothalamus. Diabetes 46: 150-152, 1997.
19. Jansen, A. S. P., X. V. Nguyen, V. Karpitskiy, T. C. Metenleiter, and A. D. Loewy. Central command neurons of the sympathetic nervous system: basis of the fight-or-flight response. Science 270: 644-646, 1995.
20. Jones, A. P., E. N. Pothos, P. Rada, D. H. Olster, and B. G. Hoebel. Maternal hormonal manipulations in rats cause obesity and increase medial hypothalamic norepinephrine release in male offspring. Dev. Brain Res. 88: 127-131, 1995.
21. Koyama, K., G. Chen, Y. Lee, and R. H. Unger. Tissue triglycerides, insulin resistance, and insulin production: implications for hyperinsulinemia of obesity. Am. J. Physiol. Endocrinol. Metab. 273: E708-E713, 1997.
22. Kraszewski, K., and A. H. Cincotta. Effect of monoamine iontophoresis on neuronal activity in ventromedial hypothalamus of lean and obese mice. Soc. Neurosci. Abstr. 23: 1794, 1977.
23. Leyva, F., I. F. Godsland, M. Ghatei, A. J. Proudler, S. Aldis, C. Walton, S. Bloom, and J. C. Stevenson. Hyperleptinemia as a component of a metabolic syndrome of cardiovascular risk. Arterioscler. Thromb. Vasc. Biol. 18: 928-933, 1998.
24. Liang, Y., M. Lubkin, H. Sheng, and A. H. Cincotta. Dopamine agonist treatment ameliorates hyperglcemia hyperlipidemia and the elevated basal insulin release from islets of ob/ob mice. Biochim. Biophys. Acta 1404: 1-13, 1998.
25. Liang, Y., S. Luo, and A. H. Cincotta. Chronic infusion of norepinephrine plus serotonin into the VMH impairs pancreatic islet function. Metabolism 48: 1287-1289, 1999.
26. Luiten, P. G. M., G. J. Ter Horst, and A. B. Steffens. The hypothalamus, intrinsic connections and outflow pathways to the endocrine system in relation to the control of feeding and metabolism. Prog. Neurobiol. 28: 1-54, 1987.
27. Luo, S., J. Luo, and A. H. Cincotta. Chronic ventromedial hypothalamic infusion of norepinephrine and serotonin promotes insulin resistance and glucose intolerance. Neuroendocrinology 70: 460-465, 1999.
28. Luo, S., J. Luo, and A. H. Cincotta. Suprachiasmatic nuclei monoamine metabolism of glucose tolerant versus intolerant hamsters. Neuroreport 10: 2073-2077, 1999.
29. Luo, S., J. Luo, S. Hodge, and A. H. Cincotta. Increased daily turnover of noradrenaline and serotonin in ventral medial hypothalamus (VMH) of obese versus lean Zucker rats assessed by in vivo microdialysis. Soc. Neurosci. Abstr. 22: 605, 1996.
30. Luo, S., J. Luo, A. H. Meier, and A. H. Cincotta. Dopaminergic neurotoxin administration to the area of the suprachiasmatic nuclei induces insulin resistance. Neuroreport 8: 3495-3499, 1997.
31. Luo, S., A. H. Meier, and A. H. Cincotta. Bromocriptine reduces obesity, glucose intolerance and extracellular monoamine metabolite levels in the ventromedial hypothalamus of Syrian hamsters. Neuroendocrinology 68: 1-10, 1998.
32. Matsuda, M., Y. Liu, S. Mahankali, Y. Pu, A. Mahankali, J. Wang, R. A. DeFronzo, P. T. Fox, and J.-H. Gao. Altered hypothalamic function in response to glucose ingestion in obese humans (Abstract). Diabetes 48, Suppl. 1: A27, 1999.
33. Meier, A. H., and A. H. Cincotta. Circadian rhythms regulate the expression of the thrifty genotype/phenotype. Diabetes Rev. 4: 464-487, 1996.
34. Minokoshi, Y., M. S. Haque, and R. Shimazu. Microinjection of leptin into the ventromedial hypothalamus increases glucose uptake in peripheral tissues in rats. Diabetes 48: 287-291, 1999.
35. Mrosovsky, N. Cyclical obesity in hibernators: the search for the adjustable regulator. In: Recent Advances in Obesity Research, edited by T. B. Van Itallie and J. Hirsch. London: Liberty, 1984, vol. 4, p. 45-56.
36. Nagai, K., and H. Nakagawa. The role of the SCN in regulation of energy metabolism. In: Central Regulation of Energy Metabolism with Special Reference to Circadian Rhythm, edited by K. Nagai and H. Nakagawa. Boca Raton, FL: CRC, 1992, p. 103-144.
37. Oltmans, G. A. Norepinephrine and dopamine levels in hypothalamic nuclei of the genetically obese mouse (ob/ob). Brain Res. 273: 369-373, 1983.
38. Opara, J. U., and J. H. Levine. The deadly quartet - the insulin resistance syndrome. South Med. J. 90: 1162-1168, 1997.
39. Pan, D. A., S. Lillioja, A. D. Kriketos, M. R. Milner, L. A. Baur, C. Bogardus, A. B. Jenkins, and L. H. Storlien. Skeletal muscle triglyceride levels are inversely related to insulin action. Diabetes 46: 983-988, 1997.
40. Paolisso, G., and B. V. Howard. Role of nonesterified fatty acids in the pathogenesis of type 2 diabetes mellitus. Diabetes Med. 15: 360-366, 1998.
41. Parkinson, W. L., and H. P. Weingarten. Dissociative analysis of ventromedial hypothalamic obesity syndrome. Am. J. Physiol. Regulatory Integrative Comp. Physiol. 259: R829-R835, 1990.
42. Ravussin, E., and J. F. Gautier. Metabolic predictors of weight gain. Int. J. Obes. Relat. Metab. Disorders 23, Suppl. 1: 37-41, 1999.
43. Reaven, E. P., D. L. Curry, and G. M. Reaven. Effect of age and sex on rat endocrine pancreas. Diabetes 36: 1397-1400, 1987.
44. Reaven, G. M., H. Lithell, and L. Landsberg. Hypertension and associated metabolic abnormalities: the role of insulin resistance and the sympathoadrenal system. New Engl. J. Med. 334: 374-381, 1996.
45. Scherrer, U., R. Owlya, and M. Lepori. Body fat and sympathetic nerve activity. Cardiovasc. Drugs Ther. 10: 215-222, 1996.
46. Scislowski, P. W. D., E. Tozzo, Y. Zhang, and A. H. Cincotta. Attenuation of diabetic and obese conditions in ob/ob mice treated with dopaminergic agonists. Int. J. Obesity 23: 425-431, 1999.
47. Shimazu, T. Neuronal regulation of hepatic glucose metabolism in mammals. Diabetes Metab. Rev. 3: 185-206, 1987.
48. Shimazu, T., M. Noma, and M. Saito. Chronic infusion of norepinephrine into the ventromedial hypothalamus induces obesity in rats. Brain Res. 369: 215-233, 1986.
49. Steffens, A. B., G. Damsma, J. van der Gugten, and P. G. M. Luiten. Circulating free fatty acids, insulin, and glucose during chemical stimulation of hypothalamus in rats. Am. J. Physiol. Endocrinol. Metab. 247: E765-E771, 1984.
50. Yoshimatsu, H., M. Egawa, and G. A. Bray. Sympathetic nerve activity after discrete hypothalamic injections of L-glutamate. Brain Res. 601: 121-128, 1993.
51. Young, R. A. Fat, energy and mammalian survival. Am. Zool. 16: 699-710, 1976.